AMENDMENT NO. 5 TO SCHEDULE TO
This Amendment No. 5 (this Amendment No. 5) amends and supplements the Tender Offer Statement on Schedule TO originally
filed by Coca-Cola Consolidated, Inc., a Delaware corporation (Coca-Cola Consolidated or the Company), on May 20, 2024 (together with any amendments or supplements
thereto, the Schedule TO) in connection with the Companys offer to purchase for cash up to $2,000 million in value of shares of its issued and outstanding Common Stock, par value $1.00 per share, at a price of not less than
$850 nor greater than $925 per share upon the terms and subject to the conditions described in the Offer to Purchase, dated May 20, 2024 (the Offer to Purchase), a copy of which was filed as
Exhibit (a)(1)(A) to the
Schedule TO, and in the related Letter of Transmittal (the Letter of Transmittal and, together with the Offer to Purchase, as they may be amended or supplemented from time to time, the Offer), a copy of which was filed as
Exhibit (a)(1)(B) to the Schedule TO.
Only those items amended or supplemented are reported in this Amendment No. 5. Except as
specifically provided herein, the information contained in the Schedule TO remains unchanged and this Amendment No. 5 does not modify any of the information previously reported on the Schedule TO. You should read this Amendment No. 5
together with the Schedule TO and all exhibits attached thereto, including the Offer to Purchase and the Letter of Transmittal, as each may be amended or supplemented from time to time.
Item 4. Terms of the Transaction.
Item 4(b) of the Schedule TO is hereby amended and supplemented by the following information:
As described in the Offer to Purchase, based on the approximate number of shares of Common Stock the Company expects to accept for payment in
the Offer at the expected price of $925 per share, the Company expects to purchase 598,619 shares of Common Stock from Carolina Coca-Cola Bottling Investments, Inc. (CCCBI), an indirect wholly-owned subsidiary of The Coca-Cola Company,
at the same price per share as the Company expects to pay in the Offer, for an aggregate purchase price of approximately $553.7 million. The Company expects to purchase the shares of Common Stock from CCCBI on the 11th business day after the expiration of the Offer pursuant to the purchase agreement, dated May 6, 2024, by and between the Company and CCCBI, subject to the satisfaction or waiver of the
conditions to the closing under the purchase agreement.
Item 5. Past Contracts, Transactions, Negotiations and Agreements.
Item 5(e) of the Schedule TO is hereby amended and supplemented by the following information:
As described in the Offer to Purchase and Item 4 of this Amendment No. 5, the Company expects to purchase 598,619 shares of Common Stock
from CCCBI, at the same price per share as the Company expects to pay in the Offer, for an aggregate purchase price of approximately $553.7 million. The Company expects to purchase the shares of Common Stock from CCCBI on the 11th business day after the expiration of the Offer pursuant to the purchase agreement, dated May 6, 2024, by and between the Company and CCCBI, subject to the satisfaction or waiver of the
conditions to the closing under the purchase agreement.
Item 7. Source and Amount of Funds or Other Consideration.
Item 7(a), (b) and (d) of the Schedule TO are hereby amended and supplemented by the following information:
The information set forth in this Amendment No. 5 under the heading Section 10 Financial Statements is
incorporated herein by reference.
Item 10. Financial Statements.
Item 10 of the Schedule TO is amended and restated in its entirety as follows: